Amanote Research

Amanote Research

  • Register
  • Sign In

Costs of Primary Biliary Cirrhosis Treatment With Ursodeoxycholic Acid in Brazil

Value in Health- United Kingdom

doi 10.1016/j.jval.2013.08.2071

Full Text

Abstract

Available in

Categories

MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental

Date

November 1, 2013

Authors

L.L.P. LemosA.D. MataR.M. GomesA.A. Guerra JuniorF.A. Acurcio

Publisher

Elsevier BV


Related search

Clinicopathological Significance of Ursodeoxycholic Acid Treatment for Asymptomatic Primary Biliary Cirrhosis: Comparison With Its Natural Course.

Acta Hepatologica Japonica
Hepatology
1990English

Ursodeoxycholic Acid Influences the Expression Ofp27kip1but Not FoxO1 in Patients With Non-Cirrhotic Primary Biliary Cirrhosis

Journal of Immunology Research
MedicineAllergyImmunology
2014English

A Patient With Asymptomatic Primary Biliary Cirrhosis Associated With Eosinophilic Infiltration and Peripheral Eosinophilia Improved by the Administration of Ursodeoxycholic Acid.

Acta Hepatologica Japonica
Hepatology
1992English

Cost Effectiveness of Using Ursodeoxycholic Acid to Treat Primary Biliary Cholangitis

British journal of hospital medicine (London, England : 2005)
Medicine
2018English

Primary Biliary Cirrhosis

Medicine
Medicine
2011English

Primary Biliary Cirrhosis

2011English

Primary Biliary Cirrhosis

The Lancet
Medicine
1997English

Primary Biliary Cirrhosis.

Gut
Gastroenterology
1991English

Primary Biliary Cirrhosis

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy